Microgravity experiments on the International Space Station helped Merck develop a faster subcutaneous version of Keytruda (pembrolizumab). This new injection cuts treatment time to minutes, improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback